The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but ...
Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years ...
Suzetrigine (Journavx) is the first non-opioid pain medication to be approved in the US in 20 years. It could help over 80 million Americans living with severe acute pain, while reducing the effects ...
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.
The US Food and Drug Administration has approved a new, nonopioid pain medication for treating moderate to severe acute pain.